We are live on
!
Find out more
BMO
Beck Mack & Oliver Portfolio holdings
AUM
$4.85B
1-Year Est. Return
9.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.9%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$3.03B
AUM Growth
+$187M
(+6.6%)
Cap. Flow
-$36.9M
Cap. Flow
% of AUM
-1.22%
Top 10 Holdings %
Top 10 Hldgs %
42.25%
Holding
227
New
13
Increased
20
Reduced
107
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$20M |
| 2 |
Credit Acceptance
CACC
|
+$5.03M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$4.83M |
| 4 |
Enterprise Products Partners
EPD
|
+$4.42M |
| 5 |
Spectrum Brands
SPB
|
+$3.69M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Matador Resources
MTDR
|
+$8.98M |
| 2 |
Lumen
LUMN
|
+$7.82M |
| 3 |
Microsoft
MSFT
|
+$4.81M |
| 4 |
Gilead Sciences
GILD
|
+$3.48M |
| 5 |
Armstrong World Industries
AWI
|
+$3.11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 35.15% |
| 2 | Healthcare | 15.99% |
| 3 | Technology | 12.78% |
| 4 | Communication Services | 9.38% |
| 5 | Industrials | 8.94% |
Similar funds
SCA
MCCA
AC
TPCW
DGI
JSTA
PBA
KCM
Beck Mack & Oliver's Q4 2019 Portfolio in Review
As of Q4 2019, Beck Mack & Oliver held 227 positions worth $3.03B, up 6.6% from $2.84B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Beck Mack & Oliver's Q4 2019 filing shows 13 new, 20 increased, 107 reduced and 9 closed positions. Its largest new stake was Spectrum Brands: 65,201 shares worth $4.19M. The largest sale was Matador Resources, an estimated $8.98M.
By sector, the portfolio is most concentrated in Financials at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Technology.
- Beck Mack & Oliver's largest Q4 2019 buy was Spectrum Brands: 65,201 shares worth $4.19M.
- Beck Mack & Oliver added most to Charles Schwab in Q4 2019, an estimated $20M increase.
- Beck Mack & Oliver's biggest Q4 2019 reduction was Matador Resources, cutting an estimated $8.98M.
- Beck Mack & Oliver fully exited Celgene Corp in Q4 2019, selling an estimated $679K.
- Beck Mack & Oliver's ten largest holdings make up 42% of its $3.03B portfolio in Q4 2019.
- Beck Mack & Oliver opened 13 new positions and closed 9 in Q4 2019.
- Beck Mack & Oliver's portfolio value rose 6.6% quarter-over-quarter to $3.03B.
Based on Beck Mack & Oliver's 13F filing for Q4 2019, filed 7 Feb 2020.